Correlation Between Sana Biotechnology and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sana Biotechnology and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Sana Biotechnology and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Apogee Therapeutics,.

Diversification Opportunities for Sana Biotechnology and Apogee Therapeutics,

0.77

Correlation Coefficient

Sana Biotechnology  Apogee Therapeutics,

Poor diversification

The 3 months correlation between Sana and Apogee is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Apogee Therapeutics,

Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Apogee Therapeutics,. In addition to that, Sana Biotechnology is 1.44 times more volatile than Apogee Therapeutics, Common. It trades about -0.21 of its total potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.06 per unit of volatility. If you would invest  5,771  in Apogee Therapeutics, Common on September 25, 2024 and sell it today you would lose (1,021) from holding Apogee Therapeutics, Common or give up 17.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sana Biotechnology  vs.  Apogee Therapeutics, Common

Sana Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Sana Biotechnology and Apogee Therapeutics,

The main advantage of trading using opposite Sana Biotechnology and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Sana Biotechnology and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.